Alkeon Capital Management
DNTH icon

Alkeon Capital Management’s Dianthus Therapeutics DNTH Stock Holding History

Alkeon Capital Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-37,500
Closed -$4.51M – 151
2020
Q2 		$4.51M Hold
37,500
– – 0.01% 133
2020
Q1 		$3.77M Hold
37,500
– – 0.02% 122
2019
Q4 		$9.1M Buy
37,500
+6,250
+20% +$1.17M 0.03% 109
2019
Q3 		$5.13M Buy
31,250
+6,250
+25% +$1.19M 0.02% 120
2019
Q2 		$5.9M Buy
+25,000
New +$6.18M 0.02% 120
2018
Q3 		– Sell
-4,250
Closed -$918K – 131
2018
Q2 		$918K Buy
+4,250
New +$959K ﹤0.01% 121

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return